Is Global Medical Reit Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSE: GMRE) stock is to Strong Buy GMRE stock.
Out of 1 analyst, 1 (100%) are recommending GMRE as a Strong Buy, 0 (0%) are recommending GMRE as a Buy, 0 (0%) are recommending GMRE as a Hold, 0 (0%) are recommending GMRE as a Sell, and 0 (0%) are recommending GMRE as a Strong Sell.
What is GMRE's forecast return on equity (ROE) for 2023-2024?
(NYSE: GMRE) forecast ROE is N/A, which is considered weak.
What is GMRE's Price Target?
According to 1 Wall Street analyst that have issued a 1 year GMRE price target, the average GMRE price target is $11.00, with the highest GMRE stock price forecast at $11.00 and the lowest GMRE stock price forecast at $11.00.
The Wall Street analyst predicted that Global Medical Reit's share price could reach $11.00 by May 8, 2024. The average Global Medical Reit stock price prediction forecasts a potential upside of 31.74% from the current GMRE share price of $8.35.
What is GMRE's forecast return on assets (ROA) for 2023-2024?
(NYSE: GMRE) forecast ROA is N/A, which is lower than the forecast US REIT - Healthcare Facilities industry average of 6.11%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.